Evidence map›Paper›PMID 42182409›Full record

ArticlebioRxiv : the preprint server for biology2026

Trypsin exhibits exopeptidase-like activity toward N-terminal arginine that biases proteomic analyses.

Evan A Ambrose, Ganapathi Kandasamy, Mia M Meulenener, Fangliang Zhang

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Evan A AmbroseGraduate Program of Cancer Biology, University of Miami Miller School of Medicine, Miami, FL, USA.ORCID 0000-0002-4090-9775
Ganapathi KandasamyDepartment of Molecular & Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL, USA.ORCID 0000-0001-8110-2567
Mia M MeulenenerDepartment of Molecular & Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL, USA.
Fangliang ZhangDepartment of Molecular & Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL, USA.ORCID 0000-0002-8373-192X

Funding

Oxidative stress response and metabolic reprogramming by protein posttranslational arginylationR01GM138557 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ZHANG, FANGLIANG · 2020 to 2023
$1.3M
Acquisition of timsTOF Pro for Complex Lipidomic AnalysesS10OD030250 · OD · UNIVERSITY OF FLORIDA · PI BASSO, KARI B · 2022 to 2022
$658k
NIGMS NIH HHS R01 GM138557NIH HHS S10 OD030250
6 · The paper itself

Abstract

Many proteomics protocols rely on enzymatic digestion of complex protein mixtures to generate peptides with predictable cleavage patterns for the mass spectrometry analysis. One of the most utilized enzymes, trypsin, is classically defined as a serine endopeptidase with high specificity for cleaving peptide bonds on the C-terminal side of internal lysine and arginine residues. Accordingly, trypsin is not expected to remove the N-terminal arginine, which may arise through posttranslational modification such as arginylation or by proteolysis exposing internal residues as the new N-termini. N-terminal arginine plays important biological roles, including functioning as an N-degron and modulating protein interactions/signaling through its positive charge. Curiously, prior mass spectrometry-based studies utilizing trypsin to identify proteins bearing N-terminal arginine have frequently reported low and inconsistent yields, suggesting potential systematic bias in current proteomic approaches. Here, we explored whether trypsin would affect the integrity of the N-terminal arginine. By using antibodies specifically recognizing N-terminal arginine of different peptides, and by using mass spectrometry peptide analysis, we show that trypsin can remove N-terminal arginine residues in an exopeptidase-like manner. This effect occurs across a range of digestion conditions consistent with standard proteomic workflows, on peptides or whole proteins, and depends on trypsin concentration, incubation time, and catalytic activity. In addition, we show that the alternative arginine-cleavage enzyme Arg-C can also affect N-terminal arginine in a sequence-dependent context. In contrast, Lys-C and LysargiNase do not exhibit such effects, providing suitable alternative digestion strategies. Together, these findings reveal an unappreciated enzymatic behavior of arginine-cleaving proteases and suggest that their widespread use may systematically compromise the detection of N-terminal arginine in proteomic studies.

Indexed as

ArginylationarginyltransferaseAteexopeptidaseMass Spectrometryposttranslational modificationtrypsin

Identifiers

PMID42182409
PMCPMC13192817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.